Esperion Therapeutics
ESPR
ESPR
101 hedge funds and large institutions have $190M invested in Esperion Therapeutics in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 28 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
6% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 16
Holders
101
Holding in Top 10
1
Calls
$2.74M
Puts
$2.77M
Top Buyers
| 1 | +$4.42M | |
| 2 | +$4.15M | |
| 3 | +$2.33M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.28M |
| 5 |
IHM
Iguana Healthcare Management
New York
|
+$1.11M |
Top Sellers
| 1 | -$4.2M | |
| 2 | -$3.37M | |
| 3 | -$2.77M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$2.37M |
| 5 |
SAM
Senzar Asset Management
New York
|
-$2.17M |